| 臺大學術典藏 |
2020-04-10T12:51:13Z |
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer
|
Cheng A.-L.; Yeh K.-H.; Chiun Hsu; Cheng W.-F.; Lin Y.-L.; Lu L.-C.; Shao Y.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2020-04-10T12:51:11Z |
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
|
Shao Y.-Y.; Liang P.-C.; Wu Y.-M.; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; Chiun Hsu; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2020-04-10T12:51:11Z |
Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study
|
Hsu C.-H.; Kang Y.K.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; Chiun Hsu; Cheng A.-L.; Yang T.-S.; Shun C.-T.; Shao Y.-Y. |
| 臺大學術典藏 |
2020-04-10T12:51:10Z |
Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size
|
Lin Z.-Z.; Shau W.-Y.; Chiun Hsu; Shao Y.-Y.; Yeh Y.-C.; Kuo R.N.-C.; Hsu C.-H.; Yang J.C.-H.; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2020-04-10T12:51:05Z |
The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia
|
Kuo H.-Y.;Lin Z.-Z.;Kuo R.;Shau W.-Y.;Lai C.-L.;Yang Y.-Y.;Shao Y.-Y.;Chiun Hsu;Cheng W.-F.;Cheng A.-L.;Yang J.C.H.;Lai M.-S.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Chiun Hsu; Cheng W.-F.; Cheng A.-L.; Yang J.C.H.; Lai M.-S. |
| 臺大學術典藏 |
2020-04-10T12:51:03Z |
Cyclin E1 inhibition can overcome sorafenib resistance in hepatocellular carcinoma cells through Mcl-1 suppression
|
Chiun Hsu; Lin L.-I.; Cheng Y.-C.; Feng Z.-R.; Shao Y.-Y.; Cheng A.-L.; Ou D.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:01Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao Y.-Y.;Chen B.-B.;Ou D.-L.;Lin Z.-Z.;Hsu C.-H.;Wang M.-J.;Cheng A.-L.;Chiun Hsu; Shao Y.-Y.; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Chiun Hsu |
| 臺大學術典藏 |
2020-04-09T09:43:08Z |
Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer
|
Wei, C. H.; Liang, Y. H.; Hsu, W. H.; Shao, Y. Y.; Lin, Y. C.; Chou, P. C.; Cheng, A. L.; Yeh, K. H. |
| 臺大學術典藏 |
2020-04-09T09:42:28Z |
Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trials
|
Shao, Y.-Y.; Shau, W.-Y.; Chan, S.-Y.; Lu, L.-C.; Hsu, C.-H.; Cheng, A.-L. |
| 臺大學術典藏 |
2020-04-09T09:40:50Z |
Influence of age on opioid prescription of patients with advanced lung cancer
|
Shao, Y. Y.; Lin, C. P.; Chen, H. M.; Lee, H. S. |
| 臺大學術典藏 |
2020-04-09T09:39:09Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao, Y. Y.; Chen, B. B.; Ou, D. L.; Lin, Z. Z.; Hsu, C. H.; Wang, M. J.; Cheng, A. L.; Hsu, C. |
| 臺大學術典藏 |
2020-04-09T09:31:03Z |
Key opioid prescription concerns in cancer patients: A nationwide study
|
Shao, Y. Y.; Lin, C. P.; Hsu, C. H.; Fu, W. M.; Chen, H. M.; Lee, Y. H.; Lai, M. S. |
| 臺大學術典藏 |
2020-03-23T07:19:27Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Cheng A.-L.; Lin C.-H.; Chang K.-J.; Kuo W.-H.; Lee W.-C.; Hsu C.; CHIUN-SHENG HUANG; Liau J.-Y.; Lu Y.-S.; Shao Y.-Y.;Kuo K.-T.;Hu F.-C.;Lu Y.-S.;Chiun-Sheng Huang;Liau J.-Y.;Lee W.-C.;Hsu C.;Kuo W.-H.;Chang K.-J.;Lin C.-H.;Cheng A.-L.; Shao Y.-Y.; Kuo K.-T.; Hu F.-C. |
| 臺大學術典藏 |
2020-03-07T06:42:17Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Shao Y.-Y.;Kuan-Ting Kuo;Hu F.-C.;Lu Y.-S.;Huang C.-S.;Liau J.-Y.;Lee W.-C.;Hsu C.;Kuo W.-H.;Chang K.-J.;Lin C.-H.;Cheng A.-L.; Shao Y.-Y.; KUAN-TING KUO; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; Chang K.-J.; Lin C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T08:04:11Z |
β-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma
|
Lu L.-C.; Shao Y.-Y.; Lee Y.-H.; MIN-SHU HSIEH; Hsiao C.-H.; Lin H.-H.; Kao H.-F.; Ma Y.-Y.; Yen F.-C.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2020-03-05T08:03:56Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Hsu C.-H.; Huang T.-C.; Shao Y.-Y.; Lien M.-Y.; Kuo H.-Y.; MIN-SHU HSIEH; Lin C.-Y.; Lin C.-C.; Guo J.-C.; Guo J.-C.;Lin C.-C.;Lin C.-Y.;Min-Shu Hsieh;Kuo H.-Y.;Lien M.-Y.;Shao Y.-Y.;Huang T.-C.;Hsu C.-H. |
| 臺大學術典藏 |
2020-03-05T07:52:40Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Shao Y.-Y.; KUAN-TING KUO; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; Chang K.-J.; Lin C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T06:28:44Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Hsu C.; Lee W.-C.; JAU-YU LIAU; Huang C.-S.; Lu Y.-S.; Kuo K.-T.; Hu F.-C.; Shao Y.-Y.; Shao Y.-Y.;Kuo K.-T.;Hu F.-C.;Lu Y.-S.;Huang C.-S.;Jau-Yu Liau;Lee W.-C.;Hsu C.;Kuo W.-H.;Chang K.-J.;Lin C.-H.;Cheng A.-L.; Kuo W.-H.; Chang K.-J.; Lin C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-20T06:53:16Z |
Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment
|
Cheng A.-L.; Shao Y.-Y.; Lin Z.-Z.; Liang P.-C.; YU-WEN TIEN |
| 臺大學術典藏 |
2020-02-19T09:33:50Z |
Dissimilar immunohistochemical expression of ERK and AKT between paired biopsy and hepatectomy tissues of hepatocellular carcinoma
|
Shao Y.-Y.; Chen C.-L.; MING-CHIH HO; Huang C.-C.; Tu H.-C.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-19T09:33:45Z |
Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases
|
Shao Y.-Y.; MING-CHIH HO; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2020-02-14T02:49:54Z |
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer
|
Lu L.-C.; Shao Y.-Y.; Hsu C.-H.; Hsu C.; WEN-FANG CHENG; Lin Y.-L.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-02-11T07:58:41Z |
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
|
Shao Y.-Y.;Liang P.-C.;Yao-Ming Wu;Huang C.-C.;Huang K.-W.;Cheng J.C.;Hsu C.-H.;Hsu C.;Cheng A.-L.;Lin Z.-Z.; Shao Y.-Y.; Liang P.-C.; YAO-MING WU; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; Hsu C.; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2020-02-10T09:00:19Z |
Integrated stable isotope labeling by amino acids in cell culture (SILAC) and isobaric tags for relative and absolute quantitation (iTRAQ) quantitative proteomic analysis identifies galectin-1 as a potential biomarker for predicting sorafenib resistance in liver cancer
|
Yeh C.-C.;Hsu C.-H.;Shao Y.-Y.;Ho W.-C.;Tsai M.-H.;Feng W.-C.;Chow L.-P.; Yeh C.-C.; Hsu C.-H.; Shao Y.-Y.; Ho W.-C.; Tsai M.-H.; Feng W.-C.; Chow L.-P.; MONG-HSUN TSAI |
| 臺大學術典藏 |
2020-02-06T05:22:05Z |
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer
|
Cheng A.-L.; Yeh K.-H.; WEN-FANG CHENG; Lin Y.-L.; Hsu C.; Hsu C.-H.; Shao Y.-Y.; Lu L.-C.; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; WEN-FANG CHENG; Hsu C.; Yeh K.-H.;Cheng A.-L.;Lin Y.-L.;WEN-FANG CHENG;Hsu C.;Hsu C.-H.;Shao Y.-Y.;Lu L.-C.; Lu L.-C.; Shao Y.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2020-02-06T05:21:56Z |
The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia
|
Lai M.-S.;Yang J.C.H.;Cheng A.-L.;WEN-FANG CHENG;Hsu C.;Shao Y.-Y.;Yang Y.-Y.;Lai C.-L.;Shau W.-Y.;Kuo R.;Lin Z.-Z.;Kuo H.-Y.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; WEN-FANG CHENG; Cheng A.-L.; Yang J.C.H.; Lai M.-S.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; WEN-FANG CHENG; Cheng A.-L.; Yang J.C.H.; Lai M.-S. |
| 臺大學術典藏 |
2020-01-22T04:47:49Z |
Integrated stable isotope labeling by amino acids in cell culture (SILAC) and isobaric tags for relative and absolute quantitation (iTRAQ) quantitative proteomic analysis identifies galectin-1 as a potential biomarker for predicting sorafenib resistance in liver cancer
|
Yeh C.-C.;Hsu C.-H.;Shao Y.-Y.;Ho W.-C.;Tsai M.-H.;Feng W.-C.;Lu-Ping Chow; Yeh C.-C.; Hsu C.-H.; Shao Y.-Y.; Ho W.-C.; Tsai M.-H.; Feng W.-C.; LU-PING CHOW |
| 臺大學術典藏 |
2020 |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
Lin Z.-Z.; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; Cheng A.-L.; Lee R.-C.; Chao Y.; CHIUN HSU |
| 國立成功大學 |
2020 |
Satisfaction with pain management and impact of pain on quality of life in cancer patients
|
Lin, J.;Hsieh, R.-K.;Chen, J.-S.;Lee, K.-D.;Rau, K.-M.;Shao, Y.-Y.;Sung, Y.-C.;Yeh, S.-P.;Chang, Chang C.-S.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Yen, C.-J.;Lai, P.-Y.;Hwang, W.-L.;Chiou, T.-J. |
| 臺大學術典藏 |
2019 |
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
|
Lu L.-C.; Shen Y.-C.; Chiun Hsu; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.; Liu T.-H.; Shao Y.-Y. |
| 臺大學術典藏 |
2019 |
Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
|
Chang C.-J.; Lee Y.-H.; Lu L.-C.;Lee Y.-H.;Chang C.-J.;Shun C.-T.;Fang C.-Y.;Shao Y.-Y.;Liu T.-H.;Cheng A.-L.;Chih-Hung Hsu; Lu L.-C.; Shun C.-T.; Fang C.-Y.; Shao Y.-Y.; Liu T.-H.; Cheng A.-L.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2019 |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C; Chia-Chi Lin; Lin C.-Y; Hsieh M.-S; Kuo H.-Y; Lien M.-Y; Shao Y.-Y; Huang T.-C; Hsu C.-H. |
| 臺大學術典藏 |
2019 |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; CHIUN HSU; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 國立成功大學 |
2019 |
A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life
|
Chou, W.-C.;Chen, J.-S.;Hung, C.-Y.;Lu, C.-H.;Shao, Y.-Y.;Chiou, T.-J.;Sung, Y.-C.;Rau, K.-M.;Yen, C.-J.;Yeh, S.-P.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Hwang, W.-L.;Lai, P.-Y.;Chang, Chang C.-S.;Hsieh, R.-K. |
| 國立成功大學 |
2019 |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu, Lu L.-C.;Hsu, C.;Shao, Y.-Y.;Chao, Y.;Yen, C.-J.;Shih, I.-L.;Hung, Y.-P.;Chang, Chang C.-J.;Shen, Y.-C.;Guo, J.-C.;Liu, T.-H.;Hsu, C.-H.;Cheng, A.-L. |
| 國立成功大學 |
2019 |
Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study
|
Cho, S.-F.;Rau, K.-M.;Shao, Y.-Y.;Yen, C.-J.;Wu, M.-F.;Chen, J.-S.;Chang, Chang C.-S.;Yeh, S.-P.;Chiou, T.-J.;Hsieh, R.-K.;Lee, M.-Y.;Sung, Y.-C.;Lee, K.-D.;Lai, P.-Y.;Yu, M.-S.;Hwang, W.-L.;Liu, T.-C. |
| 臺大學術典藏 |
2018-09-10T18:05:00Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao, Y.-Y.;Chen, B.-B.;Ou, D.-L.;Lin, Z.-Z.;Hsu, C.-H.;Wang, M.-J.;Cheng, A.-L.;Hsu, C.; BANG-BIN CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T15:38:30Z |
Key opioid prescription concerns in cancer patients: A nationwide study
|
Lin, C.-P.;Hsu, C.-H.;Fu, W.-M.;Chen, H.-M.;Lee, Y.-H.;Lai, M.-S.;Shao, Y.-Y.; CHIH-PENG LIN |
| 臺大學術典藏 |
2018-09-10T15:34:30Z |
Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer
|
Liang, Y.-H.;Wei, C.-H.;Hsu, W.-H.;Shao, Y.-Y.;Lin, Y.-C.;Chou, P.-C.;Cheng, A.-L.;Yeh, K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:40:50Z |
Ficusmicrochlorin A - C, two new methoxy lactone chlorins and an anhydride chlorin from the leaves of Ficus microcarpa
|
Chiu, H.-L.; Lu, T.-L.; Tzeng, C.-Y.; Lee, T.-H.; Lee, C.-K.; Shao, Y.-Y.; Chen, C.-R.; Chang, C.-I.; Kuo, Y.-H.; Lin, Huan-You; Chiu, Hsi-Lin; Lu, Te-Ling; Tzeng, Chih-Ying; Lee, Tzong-Huei; Lee, Ching-Kuo; Shao, Yi-Yuan; Chen, Chiy-Rong; Chang, Chi-I; Kuo, Yueh-Hsiung; Lin, H.-Y.; Chiu, H.-L.; Lu, T.-L.; Tzeng, C.-Y.; Lee, T.-H.; Lee, C.-K.; Shao, Y.-Y.; Chen, C.-R.; Chang, C.-I.; Kuo, Y.-H.; TZONG-HUEI LEE |
| 臺大學術典藏 |
2018-09-10T08:40:50Z |
Ficuschlorins A-D, lactone chlorins from the leaves of ficus microcarpa
|
TZONG-HUEI LEE;Kuo, Y.-H.;Chang, C.-I.;Chen, C.-R.;Shao, Y.-Y.;Lee, C.-K.;Lee, T.-H.;Tzeng, C.-Y.;Lan, Y.-H.;Chiu, H.-L.;Lin, H.-Y.; Lin, H.-Y.; Chiu, H.-L.; Lan, Y.-H.; Tzeng, C.-Y.; Lee, T.-H.; Lee, C.-K.; Shao, Y.-Y.; Chen, C.-R.; Chang, C.-I.; Kuo, Y.-H.; TZONG-HUEI LEE |
| 臺大學術典藏 |
2018-09-10T07:01:59Z |
Three new triterpenes from the roots of Rhus javanica L. var. roxburghiana
|
Chiu, C.-L.;Lee, T.-H.;Shao, Y.-Y.;Kuo, Y.-H.; Chiu, C.-L.; Lee, T.-H.; Shao, Y.-Y.; Kuo, Y.-H.; TZONG-HUEI LEE |
| 臺大學術典藏 |
2018-09-10T06:28:59Z |
New lignans from the heartwood of Cunninghamia lanceolata
|
Lee, T.-H.;Yeh, M.-H.;Chang, C.-I.;Lee, C.-K.;Shao, Y.-Y.;Kuo, Y.-H.; Lee, T.-H.; Yeh, M.-H.; Chang, C.-I.; Lee, C.-K.; Shao, Y.-Y.; Kuo, Y.-H.; TZONG-HUEI LEE |
| 臺大學術典藏 |
2018-09-10T05:56:49Z |
New constituents from the heartwood of Picea morrisonicola HAYATA
|
Chang, C.-I.; Lee, C.-K.; Shao, Y.-Y.; Kuo, Y.-H.; TZONG-HUEI LEE; Lee, T.-H.;Yeh, M.-H.;Chang, C.-I.;Lee, C.-K.;Shao, Y.-Y.;Kuo, Y.-H.; Lee, T.-H.; Yeh, M.-H. |
| 臺大學術典藏 |
2018-09-10T05:53:49Z |
Neuroprotective diterpenes from the fruiting body of Antrodia camphorata
|
Chen, C.-C.; Shiao, Y.-J.; Lin, R.-D.; Shao, Y.-Y.; Lai, M.-N.; Lin, C.-C.; Ng, L.-T.; Kuo, Y.-H.; LEAN-TEIK HUANG |
| 臺大學術典藏 |
2018-09-10T05:45:46Z |
Emergency department presentation of chronic peritoneal dialysis patients
|
Pai, M.-F.;Hsu, S.-P.;Peng, Y.-S.;Chiang, C.-K.;Ho, T.-I.;Shao, Y.Y.;Lee, H.-Y.;Hung, K.-Y.; CHIH-KANG CHIANG |
| 臺大學術典藏 |
2017 |
Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells
|
Shao Y.-Y.;Min-Shu Hsieh;Wang H.-Y.;Li Y.-S.;Lin H.;Hsu H.-W.;Huang C.-Y.;Hsu C.-H.;Cheng A.-L.; Shao Y.-Y.; MIN-SHU HSIEH; Wang H.-Y.; Li Y.-S.; Lin H.; Hsu H.-W.; Huang C.-Y.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2017 |
Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells
|
Lin H.; Shao Y.-Y.;Hsieh M.-S.;Wang H.-Y.;Li Y.-S.;Lin H.;Hsu H.-W.;Huang C.-Y.;Chih-Hung Hsu;Cheng A.-L.; Shao Y.-Y.; Hsieh M.-S.; Wang H.-Y.; Li Y.-S.; Hsu H.-W.; Huang C.-Y.; CHIH-HUNG HSU; Cheng A.-L. |
| 臺大學術典藏 |
2017 |
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
|
Di Laurenzio L.; Lee R.; Larson S.M.; Cheng A.-L.; Carrasquilo J.A.; Ohishi N.; Chen Y.-C.; Agajanov T.; Boisserie F.; Morikawa H.; Maki Y.; Tanaka T.; Ohtomo T.; Schwartz L.; Smith-Jones P.M.; Frenette C.; O’Neil B.; Shao Y.-Y.; Wan P.; Ma J.; Gansukh B.; Lyashchenko S.K.; Pandit-Taskar N.; Ruan S.; Beylergil V.; O’Donoghue J.; Yen C.-J.; CHIH-HUNG HSU; Abou-Alfa G.K.; Abou-Alfa G.K.;Yen C.-J.;Chih-Hung Hsu;O’Donoghue J.;Beylergil V.;Ruan S.;Pandit-Taskar N.;Gansukh B.;Lyashchenko S.K.;Ma J.;Wan P.;Shao Y.-Y.;Lin Z.-Z.;Frenette C.;O’Neil B.;Schwartz L.;Smith-Jones P.M.;Ohtomo T.;Tanaka T.;Morikawa H.;Maki Y.;Ohishi N.;Chen Y.-C.;Agajanov T.;Boisserie F.;Di Laurenzio L.;Lee R.;Larson S.M.;Cheng A.-L.;Carrasquilo J.A.; Lin Z.-Z. |
| 臺大學術典藏 |
2017 |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao Y.-Y.;Bang-Bin Chen;Ou D.-L.;Lin Z.-Z.;Hsu C.-H.;Wang M.-J.;Cheng A.-L.;Hsu C.; Shao Y.-Y.; BANG-BIN CHEN; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Hsu C. |
